■评估年龄相关性黄斑变性(AMD)患者植入非衍射焦深(EDOF)人工晶状体(IOL)的视觉结果。
■眼科实践,悉尼,澳大利亚。
■回顾性图表回顾。
■AMD患者接受白内障手术并接受非衍射EDOFAcrySofIQVivityIOL植入2年。校正后的远距视力(CDVA),远距矫正近视敏度(DCNVA;50cm),对比敏感度,中央凹厚度,VF-14问卷结果,并对可用的生活质量进行了分析。
■这项初步研究共纳入28名序贯患者(51只眼)(46%为男性,平均年龄77.4岁)。在患有晚期AMD的27只眼睛中,17(63%)有湿性AMD。患者术前平均CDVA为logMAR0.32±0.29。术后单眼CDVA和DCNVA分别为logMAR0.20±0.25和N9±5(范围N5-N36),分别。获得Snellen6/5-6/12术后CDVA的眼睛(n=42,82%),6/15-6/24(n=7,14%),大于6/24(n=2,4%)的平均DCNVA为N8(范围N5-N10),N13(范围N10-N18),和N27(范围N18-N36),分别。获得Snellen6/5-6/12的CDVA的眼睛显示在正常范围内的对比敏感度。术后VF-14问卷,Snellen6/5-6/12的CDVA患者报告视力损害轻微,而CDVA大于6/15的患者报告轻度损伤。大多数患者(96%,n=27)对术后生活质量的改善感到满意。术中无并发症。
■EDOFAcrySofIQVivityIOL可改善早期AMD患者的近视力,与远距视力成正比。
UNASSIGNED: To assess visual outcomes of the implantation of a non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) in patients with age-related macular degeneration (AMD).
UNASSIGNED: Ophthalmology practice, Sydney, Australia.
UNASSIGNED: Retrospective chart review.
UNASSIGNED: Patients with AMD undergoing cataract surgery and receiving non-diffractive EDOF AcrySof IQ Vivity IOL implantation over a 2-year period were identified. Corrected distance visual acuity (CDVA), distance-corrected near visual acuity (DCNVA; 50 cm), contrast sensitivity, central foveal thickness, VF-14 questionnaire results, and quality of life where available were analyzed.
UNASSIGNED: A total of 28 sequential patients (51 eyes) were included in this pilot study (46% male, mean age 77.4 years). Of 27 eyes that had late AMD, 17 (63%) had wet AMD. Mean patient preoperative CDVA was logMAR 0.32±0.29. Postoperative monocular CDVA and DCNVA were logMAR 0.20±0.25 and N9±5 (range N5-N36), respectively. Eyes achieving postoperative CDVA of Snellen 6/5-6/12 (n=42, 82%), 6/15-6/24 (n=7, 14%), and greater than 6/24 (n=2, 4%) achieved a mean DCNVA of N8 (range N5-N10), N13 (range N10-N18), and N27 (range N18-N36), respectively. Eyes achieving CDVA of Snellen 6/5-6/12 showed contrast sensitivity within the normal range. On postoperative VF-14 questionnaire, patients with CDVA of Snellen 6/5-6/12 reported minimal visual impairment, while patients with CDVA greater than 6/15 reported mild impairment. A majority of patients (96%, n=27) were satisfied with the improvement in quality of life postoperatively. No intraoperative complications were reported.
UNASSIGNED: The EDOF AcrySof IQ Vivity IOL provides improved near vision proportional to distance vision in patients with early AMD.